Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Zinman

Showing results (171-180 of 217) with videos related to

Pageof 22
Sort By:
Diabetologia|November 21, 2007
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinedionesD M Nathan, J B Buse, M B Davidson, et al.
Diabetes, Obesity & Metabolism|August 7, 2012
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programmeK Niswender, X Pi-Sunyer, J Buse, et al.
Diabetes Care|February 1, 1997
The prevalence of NIDDM and associated risk factors in native CanadiansS B Harris, J Gittelsohn, A Hanley, et al.
Diabetologia|October 23, 2008
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesD M Nathan, J B Buse, M B Davidson, et al.
Diabetologia|June 28, 2006
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesD M Nathan, J B Buse, M B Davidson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 26, 2005
Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetesR L Pollex, A J G Hanley, B Zinman, et al.
Clinical Chemistry and Laboratory Medicine|August 22, 2000
Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populationsS Fanella, S B Harris, T K Young, et al.
Bulletins Et Memoires De La Societe Francaise D'Ophtalmologie|January 1, 1982
[Risk factors in proliferating diabetic retinopathy]M S Roy, A K Hanna, B Zinman, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1988
The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitusT D Ruddy, S L Shumak, P P Liu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 20, 2013
Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trialH W Rodbard, B Cariou, B Zinman, et al.
Pageof 22

Showing results (171-180 of 217) with videos related to

Sort By:
Pageof 22
Diabetologia|November 21, 2007
Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinedionesD M Nathan, J B Buse, M B Davidson, et al.
Diabetes, Obesity & Metabolism|August 7, 2012
Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programmeK Niswender, X Pi-Sunyer, J Buse, et al.
Diabetes Care|February 1, 1997
The prevalence of NIDDM and associated risk factors in native CanadiansS B Harris, J Gittelsohn, A Hanley, et al.
Diabetologia|October 23, 2008
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesD M Nathan, J B Buse, M B Davidson, et al.
Diabetologia|June 28, 2006
Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesD M Nathan, J B Buse, M B Davidson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 26, 2005
Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetesR L Pollex, A J G Hanley, B Zinman, et al.
Clinical Chemistry and Laboratory Medicine|August 22, 2000
Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populationsS Fanella, S B Harris, T K Young, et al.
Bulletins Et Memoires De La Societe Francaise D'Ophtalmologie|January 1, 1982
[Risk factors in proliferating diabetic retinopathy]M S Roy, A K Hanna, B Zinman, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1988
The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitusT D Ruddy, S L Shumak, P P Liu, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 20, 2013
Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trialH W Rodbard, B Cariou, B Zinman, et al.
Pageof 22